Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34⁺ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose Chemotherapy

References

• Reiffers, J., Castaigne, S., Tilly, H., Lepage, E., Leverger, G., Henon, P and Douay, L. (1987). Hematopoietic reconstitution after autologous blood stem cell transplantation: a report of 45 cases. Plasma Ther Transfus Technol, 8, 360–365.
   Web of Science ®Google Scholar
• Schwartzberg, L., Birch, R., Blanco, R., Wittin, F., Muscato, J., Trauer, K., Hazelton, B. and West, W. (1993). Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion atone following high-dose chemotherapy. Bone Marrow Transplant, 11, 369–374.
   PubMed Web of Science ®Google Scholar
• López, M., Mortel, O., Pouillart, P., Zucker, J. M., Fechtenbaum, J., Douay, L., Palangie, T., Michon, J., Salmon, D. and Gorin, N. C. (1991). Acceleration of hematopoietic recovery after autologous bone marrow transplantation by low doses of peripheral blood stem cells. Bone Marrow Transplant, 7, 173–181.
   PubMed Web of Science ®Google Scholar
• Sola, C., Mendoza, L., Amill, B., Mesia, R., Rueda, A., Alonso, M. C., Ojeda, B., Artigas, V., Tugues, D., Garcia, J. and López López, J. (1995). Quimioterapia intensiva con soporte de células progenitoras hematopoyéticas periféricas movilizadas con ciclofosfamida a dosis altas y G-CSF: rápida recuperación hematológica. Rev Clin Esp, 195, 83–88.
   PubMedGoogle Scholar
• Peters, W. P., Rosner, G., Ross, M., Vredenburgh, J., Meisenberg, B., Gilbert, C. and Kurtzberg, J. (1993). Comparative effects of GM-CSF and G-CSF on priming peripheral blood progenitor cells for use with autologous bone marrow after high dose chemotherapy. Blood, 81, 1709–1719.
   PubMed Web of Science ®Google Scholar
• Kotasek, D., Shepherd, K. M., Sage, R. E., Dale, B. M., Norman, J. E., Charles, P., Gregg, A., Pillow, A. and Bolton, A. (1992). Factors affecting blood stem cell collections following high-dose Cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transpl, 9, 11–17.
   PubMed Web of Science ®Google Scholar
• Haas, R., Mohle, R., Fruhauf, S., Goldschmidt, H., Witt, B., Flentje, M., Wannenmacher, M. and Hunstein, W. (1994). Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood, 83, 3787–3794.
   PubMed Web of Science ®Google Scholar
• Bensinger, V. J., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., Goolel, T., Demirer, T., Schiffman, K., Weaver, C., Clift, R., Chuncey, T., Klarnet, J., Montgomery, P., Petersdorf, S., Weiden, P., Witherspoon, R. and Buckner, D. (1994). Peripheral blood stem cells collected after recombinant granulocyte colony stimulating factor: an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol, 87, 825–831.
   PubMed Web of Science ®Google Scholar
• Bensinger, W., Appelbaum, F., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., Weaver, C., Clift, R., Chaunccey, T., Klarnet, J., Montgomery, P., Petersdorf, S., Weiden, P., Witherspoon, R. and Buckner, D. (1995). Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol, 13, 2547–2555.
   PubMed Web of Science ®Google Scholar
• Schwella, N., Siegert, W., Beyer, J., Rick, O., Zingsem, J., Eckstein, R., Serke, S. and Huhn, D. (1995). Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the infused cell dose with hematopoietic reconstitution. Ann Hematol, 71, 227–234.
   PubMed Web of Science ®Google Scholar
• Weaver, C. H., Hazelton, B., Birch, R., Palmer, P., Allen, C., Schwartzberg, L. and West, W. (1995). An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood, 86, 3961–3969.
   PubMed Web of Science ®Google Scholar
• Sutherland, H. J., Eaves, C. J., Lansdörp, P. M., Philips, G. L. and Hogge, D. E. (1994). Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood, 83, 3808–3814.
   PubMed Web of Science ®Google Scholar
• Kiss, J. E., Rybka, W. B., Winkelstein, A., deMagalhaes-Silverman, M., Lister, J., D'Andrea, P. and Ball, E. D. (1997). Relationship CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant, 19, 303–310.
   PubMed Web of Science ®Google Scholar
• Miller, A. B., Hoogstraten, B., Staquet, M. and Winkler, A. (1981). Reporting results of cancer treatment. Cancer, 47, 207–214.
   PubMed Web of Science ®Google Scholar
• Garcia, J. and Martinez, E. (1983). La criopreservación de precursores hematopoyéticos: su papel en Hematología y Oncología. Bio Clin Hematol, 5, 99–107.
   Google Scholar
• Gaspard, M. H., Maraninchi, D., Stoppa, A. M., Gastaut, J. A., Michel, G., Tubiana, N., Blaise, D., Novakovitch, G., Rossi, J. F. and Weiler, P. J. (1988). Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies. Cancer Chemother Pharmacol, 22, 256–62.
   PubMed Web of Science ®Google Scholar
• Motzer, R. J., Gulati, S. C., Crown, J. P., Weisen, S., Doherty, M., Herr, H., Fair, W., Sheinfeld, J., Sogani, P., Russo, P. and Bosl, G. J. (1992). High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated. Cancer, 69, 550–556.
   PubMed Web of Science ®Google Scholar
• Antman, K., Ayash, L., Elías, A., Wheeler, C., Hunt, M., Eder, J. P., Teicher, B. A., Critchlow, J., Bibbo, J., Schnipper, L. E. and Frei, E. III. (1992). A phase II study of high dose cyclophosphamide, thiotepa and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard dose therapy. J Clin Oncol, 10, 102–110.
   PubMed Web of Science ®Google Scholar
• To, L. B., Davy, M. L. J., Haylock, D. N., Dyson, P. G., Thorp, D. and Juttner, C. A. (1989). Autotransplantation using peripheral blood stem cells mobilized by cyclophosphamide. Bone Marrow Transplant, 4, 595–596.
   PubMed Web of Science ®Google Scholar
• Gianni, A. M., Bregni, M., Siena, S., Villa, S., Sciorelli, G. A., Ravagnani, F., Pellegris, G. and Bonadonna, G. (1989). Rapid and complete hematopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemoradiotherapy? Hematol Oncol, 7, 139–148.
   PubMed Web of Science ®Google Scholar
• To, L. B., Sheppard, K. M., Haylock, C. M., Dyson, P. G., Charles, P., Thorp, D. L., Dale, B. M., Dart, G. W., Roberts, M. M., Sage, R. E. and Juttner, C. A. (1990). Single high doses of cyclophosphamide enable the collection of high numbers of hematopoietic stem cells from the peripheral blood. Exp Hematol, 18, 442–447.
   PubMed Web of Science ®Google Scholar
• Siena, S., Bregni, M., Brando, B., Ravagnani, F., Bonadonna, G. and Gianni, M. (1989). Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose Cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocytemacrophage colony-stimulating factor. Blood, 6, 1905–1914.
   Google Scholar
• Gianni, A. M., Siena, S., Bregni, M., Tarella, C., Stern, A. C., Pileri, A. and Bonadonna, G. (1989). Granulcyte-macrophage colony-stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet, 2, 580–585.
   PubMed Web of Science ®Google Scholar
• Ravagnani, F., Siena, S., Bregni, M., Sciorelli, G., Gianni, A. M. and Pellegris, G. (1990). Large-scale collection of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF. Eur J Cancer, 26, 562–564.
   PubMed Web of Science ®Google Scholar
• Schwartzberg, L. S., Birch, R., Hazelton, B., Tauer, K. W., Lee, P., Altemose, R., George, C., Blanco, R., Wittlin, F., Cohen, J., Muscato, J. and West, W. H. (1992). Peripheral blood stem cell mobilization by chemotherapy with and without rhG-CSF. J Hematother, 1, 317–328.
   PubMedGoogle Scholar
• Rowlings, P. A., Bayly, J. L., Rawling, C. M., Juttner, C. A. and To, L. B. (1992). A comparison of peripheral blood stem cell mobilization after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancer. Aust NZ J Med, 22, 660–664.
   PubMedGoogle Scholar
• Brugger, W., Bross, K., Frisch, J., Dern, P., Weber, B., Mertelsmann, R. and Kanz, L. (1992). Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. Blood, 79, 1193–1200.
   PubMed Web of Science ®Google Scholar
• Craig, J. I. O., Anthony, R. S., Stewart, A., Thomson, E. B. and Gillon, J. (1993). Peripheral blood stem cell mobilization using high-dose cyclophosphamide and GCSF in pretreated patients with lymphoma. Br J Hematol, 85, 210–212.
   PubMed Web of Science ®Google Scholar
• Shepherd, K. M., Charles, P., Sage, R. E., Dale, B. M., Norman, J. E., Kotasek, D., Gregg, A. and Futter, J. (1991). Mobilization of hemopoietic stem cell by Cyclophosphamide into the peripheral blood of patients with haematological malignancies. Clin Lab Haematol, 13, 25–32.
   PubMedGoogle Scholar
• Passos-Coelho, J., Braine, H. G., Davis, J. M., Huelskamp, A. M., Schepers, K. G., Ohly, K., Clarke, B., Wright, S. K., Noga, S. J., Davidson, N. E. and Kennedy, M. J. (1995). Predictive factors for peripheral blood progenitor cell collections using a single large volume leukapheresis after cyclophosphamide and granulocyte macrophage colony stimulating factor mobilization. J Clin Oncol, 13, 705–714.
   PubMed Web of Science ®Google Scholar
• Fruehauf, S., Haas, R., Conradt, C., Murea, S., Witt, B., Möhle, R. and Hunstein, W. (1995). Peripheral blood progenitor cell counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgastrim (R-metHuG-CSF)-supported cytotoxic chemotherapy. Blood, 85, 2619–2626.
   PubMed Web of Science ®Google Scholar
• Jones, H. M., Jones, S. A., Watts, M. J., Khwaja, A., Mills, W., Fielding, A., Goldstone, A. H. and Linch, D. C. (1994). Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol, 12, 1693–1702.
   PubMed Web of Science ®Google Scholar
• Civin, C. I., Strauss, L. C., Brovall, C., Fackler, M. J., Schwartz, J. F. and Shaper, J. H. (1984). Antigenic analysis of hematopoiesis III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. J Immunol, 133, 157–165.
   PubMed Web of Science ®Google Scholar
• Siena, S., Bregni, M., Brando, B., Belli, N., Ravagnani, F., Gandola, L., Stem, A. C., Lansdorp, P. M., Bonadonna, G. and Gianni, A. M. (1991). Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77, 400–409.
   PubMed Web of Science ®Google Scholar
• Sheridan, W. P., Begley, C. G., Juttner, C. A., Szer, J., To, J. B., Maher, D., McGrath, K. M., Morstyn, G. and Fox, R. M. (1992). Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, 640–644.
   PubMed Web of Science ®Google Scholar
• Hohaus, S., Goldschmidt, H., Ehrhardt, R. and Haas, R. (1993). Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus G-CSF. Exp Hematol, 21, 508–514.
   PubMed Web of Science ®Google Scholar
• Brice, P., Marolleu, J. P., Dombret, H., Leapage, E., Baruchel, A., Adam, M., Micleas, J. M., Sitthy, X. and Gisselbrecht, C. (1992). Autologous peripheral blood stem cell transplantation after high-dose therapy in patients with advanced lymphomas. Bone Marrow Transplant, 9, 337–342.
   PubMed Web of Science ®Google Scholar
• Reiffers, J., Faberes, C., Boiron, J. M., Marit, G., Foures, C., Ferrer, A. M., Cony-Makhoul, P., Puntous, M., Bernard, P., Vezon, G. and Broustet, A. (1994). Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: Analysis of factors affecting the rate of engraftment. J Hematother, 3, 185–191.
   PubMedGoogle Scholar
• Spitzer, G., Adkins, D. R., Spencer, V., Dunphy, F. R., Petruska, P. J., Velasquez, W. S., Bowers, C. E., Kronmueller, N., Niemeyer, R. and McIntyre, W. (1994). Randomized study of growth factors post-peripheral-blood stem-cell transplant: Neutrophil recovery is improved with modest clinical benefit. J Clin Oncol, 12, 661–670.
   PubMed Web of Science ®Google Scholar
• Klump, T. R., Mangan, K. F., Goldberg, S. L., Pearlman, E. S. and Mcdonald, J. S. (1995). Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: A prospective, randomized trial. J Clin Oncol, 13, 1323–1327.
   PubMed Web of Science ®Google Scholar
• Hornedo, J., Sola, C., Solano, C., Lluch, A., Benavides, M., Lopez, J. J., Garcia Conde, J. and Cortes Funes, H. (1996). Multicenter, prospective, randomized study of the role of granulocyte colony-stimulating factor (G-CSF) in the postransplant period following high-dose chemotherapy (HDC), supported with G-CSF-mobilized peripheral blood stem cells in breast cancer patients. Ann Oncol, 7(5), 63.
   Google Scholar
• Weaver, C. H., Potz, J., Redmond, J., Tauer, K., Schwartzberg, L. S., Kay win, P., Dropkin, R., Grant, B., Unger, P., Allen, C., Longin, K., Zhen, B., Hazelton, B. and Buckner, C. D. (1997). Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content. Bone Marrow Transplant, 19, 1103–1110.
   PubMed Web of Science ®Google Scholar
• Teshima, T., Harada, M., Takamatsu, Y., Makino, K., Taniguchi, S., Inaba, S., Kondo, S., Tanaka, T., Akashi, K., Minamishima, I., Ishii, E., Nishimura, J. and Niho, Y. (1992). Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting. Bone Marrow Transplant, 10, 215–220.
   PubMed Web of Science ®Google Scholar
• Dercksen, M. W., Rodenhuis, S., Dirkson, M. K. A., Schaasberg, W. P., Baars, J. W., van der Wall, E., Slaper-Cortenbach, I. C. M., Pinedo, H. M., Von dem Borne, A. E. G. Kr, van der Schoot, C. E. and Gerritsen, W. R. (1995). Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation. J Clin Oncol, 13, 1922–1932.
   PubMed Web of Science ®Google Scholar
• Tricot, G., Jagannath, S., Vesole, D., Nelson, J., Tindle, S., Miller, L., Cheson, B., Crowley, J. and Barlogie, B. (1995). Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood, 85, 588–596.
   PubMed Web of Science ®Google Scholar
• Mick, R., Williams, S. F. and Bitran, J. D. (1990). Patients at increased risk for late engraftment after transplantation: a novel method for their identification. Bone Marrow Transplant, 6, 185–191.
   PubMed Web of Science ®Google Scholar
• To, L. B., Haylock, D. N., Dowse, T., Simmons, P. J., Trimboli, S., Ashman, L. K. and Juttner, C. A. (1994). A comparative study of the phenotype and proliferative capacity of peripheral blood CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. Blood, 84, 2930–2939.
   PubMed Web of Science ®Google Scholar